Published in Blood Weekly, November 2nd, 2006
"We examined a new treatment combination of gentian violet and dye-laser. A 55-year-old male renal transplant recipient was treated with dye-laser at 585 nm after application of gentian violet 0.5%," wrote A. Faurschou and colleagues, Bispebjerg Hospital, Department of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.